by Doug Broeska, PhD May 8, 2013 The youngest-ever recipient of an artificial trachea, coated with cells produced from her own body, made history last week as well as headlines around the world. What is the connection between CCSVI and an artificial trachea implant? It’s substantial—and important to you, if you are suffering from MS. [...]

There is no doubt there has been intense world-wide focus on Dr. Paolo Zamboni’s hypothesis since his study in 2009 suggested “clinical improvement” in MS patients with narrowing of the cervical veins, otherwise known as CCSVI. The hope of the neck vein-widening “liberation therapy” was that full drainage of the central nervous system would be [...]

My name is Stephen Lovatt. I am a 49 year old MS patient who, after 12 years of diagnosis, progressed (I believe) from a relapsing/remitting type of MS to the secondary progressive phase of the disease in 2010. Desperate for relief, or at least a disruption of my rapidly advancing disease, I twice had the [...]

By Doug Broeska, PhD On July 23, 2012, the US District Court in Washington, DC affirmed the right of the Food and Drug Administration (FDA) to regulate therapies involving a patient’s own processed stem cells, otherwise known as autologous cells. The case hinged on whether the court agreed with the FDA that such stem cells [...]

Background… A significant world-wide population of multiple sclerosis (MS) patients have a chronic progressive neurological disease that is characterized by increasing disabilities. No treatments are currently available that slow, halt, or reverse the advancement of the disease in established cases of MS. The frustration in a growing number of patients and their readiness to pursue [...]